SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017311
Filing Date
2023-11-02
Accepted
2023-11-02 07:00:44
Documents
75
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elev-20230930x10q.htm   iXBRL 10-Q 2289600
2 EX-10.1 elev-20230930xex10d1.htm EX-10.1 26141
3 EX-10.2 elev-20230930xex10d2.htm EX-10.2 26244
4 EX-31.1 elev-20230930xex31d1.htm EX-31.1 15583
5 EX-31.2 elev-20230930xex31d2.htm EX-31.2 15555
6 EX-32 elev-20230930xex32.htm EX-32 8162
  Complete submission text file 0001558370-23-017311.txt   8279473

Data Files

Seq Description Document Type Size
7 EX-101.SCH elev-20230930.xsd EX-101.SCH 50343
8 EX-101.CAL elev-20230930_cal.xml EX-101.CAL 39934
9 EX-101.DEF elev-20230930_def.xml EX-101.DEF 209303
10 EX-101.LAB elev-20230930_lab.xml EX-101.LAB 464276
11 EX-101.PRE elev-20230930_pre.xml EX-101.PRE 364063
69 EXTRACTED XBRL INSTANCE DOCUMENT elev-20230930x10q_htm.xml XML 1452476
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40523 | Film No.: 231369988
SIC: 2836 Biological Products, (No Diagnostic Substances)